Across TCGA pan-cancer cohorts, SNORA3C RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of SNORA3C’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where SNORA3C RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNORA3C is over-expressed in tumor.

LUSC, READ, and HNSC are the cancer types where SNORA3C tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNORA3C RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	+0.195	.006	4	view →
READ	All	All	+0.512	.028	1	view →
HNSC	All	All	+0.106	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: SNORA3C RNA expression & survival · all SNORA3C data types